Renowned hematologist David A. Williams takes chief scientific officer post at Boston Children's Hospital
David A. Williams, MD, an internationally-recognized pediatric hematologist and oncologist, has been named Boston Children¹s Hospital¹s first chief scientific officer.
Williams currently serves as chief of hematology/oncology and director of clinical and translational research at Boston Children¹s, as well as president of Dana-Farber/Boston Children¹s Cancer and Blood Disorders Center and director of its pediatric hematology/oncology fellowship training program.
He also teaches pediatrics at Harvard Medical School.
In his new position, he is charged with driving the future of Boston Children's research enterprise and growing the hospital¹s precision medicine capabilities.
[See also: Boston Children's, IBM Watson take on rare diseases.]
Williams' own research has focused on the biology of blood stem cells, leukemia and gene therapy. He founded Dana-Farber/Boston Children¹s gene therapy program, and he is a co-founder of the Coalition for Pediatric Medical Research, a national advocacy organization.
Research is a critical part of our hospital's mission, Boston Children's President and CEO Sandra L. Fenwick, said in a statement. "David's passion, and one goal in his new position, is to help drive innovation through translation of Boston Children's outstanding biomedical discovery research to benefit patients and, in turn, to use our unique patient populations to drive additional discoveries."
Twitter: @Bernie_HITN
Email the writer: bernie.monegain@himssmedia.com
